(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1606030 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of USP9X mRNA CTD PMID:22079256 (1->4)-beta-D-glucan multiple interactions ISO RGD:1557828 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of USP9X mRNA CTD PMID:36331819 1,2-dimethylhydrazine decreases expression ISO RGD:1557828 6480464 1, 2-Dimethylhydrazine results in decreased expression of USP9X mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of USP9X mRNA CTD PMID:29097150 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of USP9X mRNA CTD PMID:32145629 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1606030 6480464 2 more ... CTD PMID:31675489 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1557828 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1557828 6480464 Tetrachlorodibenzodioxin affects the expression of USP9X mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of USP9X mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of USP9X mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4,6-tribromophenol decreases expression ISO RGD:1606030 6480464 2 more ... CTD PMID:31675489 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of USP9X mRNA CTD PMID:21346803 3-methylcholanthrene increases expression ISO RGD:1557828 6480464 Methylcholanthrene results in increased expression of USP9X mRNA CTD PMID:25926378 5-fluorouracil affects response to substance ISO RGD:1606030 6480464 USP9X protein affects the susceptibility to Fluorouracil CTD PMID:16217747 aconitine increases expression EXP 6480464 Aconitine results in increased expression of USP9X protein CTD PMID:33236894 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of USP9X mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO RGD:1557828 6480464 Aflatoxin B1 results in increased expression of USP9X mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression ISO RGD:1606030 6480464 Tretinoin results in decreased expression of USP9X mRNA CTD PMID:15498508 all-trans-retinoic acid increases expression ISO RGD:1606030 6480464 Tretinoin results in increased expression of USP9X mRNA CTD PMID:23724009 antirheumatic drug decreases expression ISO RGD:1606030 6480464 Antirheumatic Agents results in decreased expression of USP9X mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1606030 6480464 aristolochic acid I results in decreased expression of USP9X mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:1606030 6480464 arsenite inhibits the reaction [G3BP1 protein binds to USP9X mRNA] CTD PMID:32406909 atrazine decreases expression ISO RGD:1606030 6480464 Atrazine results in decreased expression of USP9X mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:1557828 6480464 Benzo(a)pyrene results in decreased expression of USP9X mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:1606030 6480464 Benzo(a)pyrene affects the methylation of USP9X 5' UTR, Benzo(a)pyrene affects the methylation of USP9X intron CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1606030 6480464 7 more ... CTD PMID:19150397 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of USP9X mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1606030 6480464 bisphenol A results in decreased expression of USP9X protein CTD PMID:31675489 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of USP9X mRNA CTD PMID:30816183 more ... bisphenol F increases expression ISO RGD:1606030 6480464 bisphenol F results in increased expression of USP9X protein CTD PMID:34186270 butanal decreases expression ISO RGD:1606030 6480464 butyraldehyde results in decreased expression of USP9X mRNA CTD PMID:26079696 caffeine decreases phosphorylation ISO RGD:1606030 6480464 Caffeine results in decreased phosphorylation of USP9X protein CTD PMID:35688186 CGP 52608 multiple interactions ISO RGD:1606030 6480464 CGP 52608 promotes the reaction [RORA protein binds to USP9X gene] CTD PMID:28238834 chlordecone increases expression ISO RGD:1557828 6480464 Chlordecone results in increased expression of USP9X mRNA CTD PMID:33711761 chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of USP9X mRNA CTD PMID:30744511 chlorpyrifos decreases expression ISO RGD:1557828 6480464 Chlorpyrifos results in decreased expression of USP9X mRNA CTD PMID:20350560 chromium(6+) decreases expression ISO RGD:1606030 6480464 chromium hexavalent ion results in decreased expression of USP9X mRNA CTD PMID:30690063 cocaine increases expression ISO RGD:1557828 6480464 Cocaine results in increased expression of USP9X mRNA CTD PMID:20056891 cocaine multiple interactions ISO RGD:1557828 6480464 EHMT2 inhibits the reaction [Cocaine results in increased expression of USP9X mRNA] CTD PMID:20056891 copper(II) sulfate increases expression ISO RGD:1606030 6480464 Copper Sulfate results in increased expression of USP9X mRNA CTD PMID:19549813 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of USP9X mRNA CTD PMID:21266533 dioxygen increases expression ISO RGD:1557828 6480464 Oxygen deficiency results in increased expression of USP9X mRNA CTD PMID:24205000 dorsomorphin multiple interactions ISO RGD:1606030 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of USP9X mRNA CTD PMID:27188386 elemental selenium decreases expression ISO RGD:1606030 6480464 Selenium results in decreased expression of USP9X mRNA CTD PMID:19244175 entinostat increases expression ISO RGD:1606030 6480464 entinostat results in increased expression of USP9X mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1606030 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of USP9X mRNA CTD PMID:27188386 enzyme inhibitor multiple interactions ISO RGD:1606030 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of USP9X protein CTD PMID:23301498 fenofibrate increases expression ISO RGD:1557828 6480464 Fenofibrate results in increased expression of USP9X mRNA CTD PMID:21318169 fenofibrate multiple interactions ISO RGD:1557828 6480464 PPARA protein affects the reaction [Fenofibrate results in increased expression of USP9X mRNA] CTD PMID:21318169 fipronil increases expression EXP 6480464 fipronil results in increased expression of USP9X mRNA CTD PMID:23962444 flutamide increases expression EXP 6480464 Flutamide results in increased expression of USP9X mRNA CTD PMID:24136188 folic acid decreases expression ISO RGD:1557828 6480464 Folic Acid results in decreased expression of USP9X mRNA CTD PMID:25629700 ivermectin decreases expression ISO RGD:1606030 6480464 Ivermectin results in decreased expression of USP9X protein CTD PMID:32959892 menadione affects expression ISO RGD:1606030 6480464 Vitamin K 3 affects the expression of USP9X mRNA CTD PMID:20044591 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of USP9X mRNA CTD PMID:30467583 methidathion decreases expression ISO RGD:1557828 6480464 methidathion results in decreased expression of USP9X mRNA CTD PMID:34813904 methylmercury chloride decreases expression ISO RGD:1606030 6480464 methylmercuric chloride results in decreased expression of USP9X mRNA CTD PMID:28001369 methylmercury chloride multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of USP9X mRNA CTD PMID:30744511 methylparaben increases expression ISO RGD:1606030 6480464 methylparaben results in increased expression of USP9X mRNA CTD PMID:31745603 miconazole decreases expression ISO RGD:1557828 6480464 Miconazole results in decreased expression of USP9X mRNA CTD PMID:27462272 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of USP9X gene CTD PMID:33148267 N-methylformamide increases expression ISO RGD:1557828 6480464 methylformamide analog results in increased expression of USP9X mRNA, methylformamide results in increased expression of USP9X mRNA CTD PMID:17040096 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of USP9X mRNA CTD PMID:22110744 nickel subsulfide increases expression EXP 6480464 nickel subsulfide results in increased expression of USP9X mRNA CTD PMID:21086188 nickel sulfate decreases expression ISO RGD:1606030 6480464 nickel sulfate results in decreased expression of USP9X mRNA CTD PMID:22714537 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of USP9X mRNA CTD PMID:25729387 paracetamol decreases expression ISO RGD:1606030 6480464 Acetaminophen results in decreased expression of USP9X mRNA CTD PMID:21420995 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of USP9X mRNA CTD PMID:33387578 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1557828 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of USP9X mRNA CTD PMID:36331819 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of USP9X gene CTD PMID:33148267 phlorizin decreases expression ISO RGD:1557828 6480464 Phlorhizin results in decreased expression of USP9X mRNA CTD PMID:22538082 potassium chromate multiple interactions ISO RGD:1606030 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of USP9X mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1606030 6480464 potassium chromate(VI) results in decreased expression of USP9X mRNA CTD PMID:22079256 , PMID:22714537 raloxifene decreases expression ISO RGD:1557828 6480464 Raloxifene Hydrochloride results in decreased expression of USP9X mRNA CTD PMID:33269387 resveratrol multiple interactions ISO RGD:1606030 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of USP9X mRNA CTD PMID:23557933 SB 431542 multiple interactions ISO RGD:1606030 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of USP9X mRNA CTD PMID:27188386 selenium atom decreases expression ISO RGD:1606030 6480464 Selenium results in decreased expression of USP9X mRNA CTD PMID:19244175 sodium arsenate increases expression ISO RGD:1557828 6480464 sodium arsenate results in increased expression of USP9X mRNA CTD PMID:21795629 sodium arsenite increases expression ISO RGD:1557828 6480464 sodium arsenite results in increased expression of USP9X mRNA CTD PMID:36209798 succimer multiple interactions ISO RGD:1557828 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of USP9X mRNA, [Succimer co-treated with Magnetite Nanoparticles] affects the expression of USP9X mRNA CTD PMID:21641980 , PMID:26378955 tamibarotene affects expression ISO RGD:1606030 6480464 tamibarotene affects the expression of USP9X mRNA CTD PMID:15498508 temozolomide decreases expression ISO RGD:1606030 6480464 Temozolomide results in decreased expression of USP9X mRNA CTD PMID:31758290 tert-butyl hydroperoxide increases expression ISO RGD:1606030 6480464 tert-Butylhydroperoxide results in increased expression of USP9X mRNA CTD PMID:15336504 testosterone decreases expression ISO RGD:1606030 6480464 Testosterone results in decreased expression of USP9X mRNA CTD PMID:33359661 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of USP9X mRNA CTD PMID:30723492 thapsigargin increases expression ISO RGD:1557828 6480464 Thapsigargin results in increased expression of USP9X protein CTD PMID:24648495 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of USP9X mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of USP9X mRNA CTD PMID:25729387 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of USP9X mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:1606030 6480464 trichostatin A results in decreased expression of USP9X mRNA CTD PMID:24935251 valproic acid decreases expression ISO RGD:1606030 6480464 Valproic Acid results in decreased expression of USP9X mRNA CTD PMID:23179753 , PMID:24935251 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of USP9X mRNA CTD PMID:29427782 valproic acid decreases methylation ISO RGD:1606030 6480464 Valproic Acid results in decreased methylation of USP9X gene CTD PMID:29154799 vitamin E decreases expression ISO RGD:1606030 6480464 Vitamin E results in decreased expression of USP9X mRNA CTD PMID:19244175
